Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Newman

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Nature|June 11, 1987
Myristylation of picornavirus capsid protein VP4 and its structural significanceM Chow, J F Newman, D Filman, et al.
Virology|January 10, 1995
Characterization of an acid-resistant mutant of foot-and-mouth disease virusT Twomey, L L France, S Hassard, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 1994
Circular dichroism, molecular modeling, and serology indicate that the structural basis of antigenic variation in foot-and-mouth disease virus is alpha-helix formationL L France, P G Piatti, J F Newman, et al.
Journal of Virological Methods|April 1, 1997
Baculovirus expressed 2C of foot-and-mouth disease virus has the potential for differentiating convalescent from vaccinated animalsR F Meyer, G D Babcock, J F Newman, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 1997
A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long-lasting protective neutralizing antibodiesJ P Briand, N Benkirane, G Guichard, et al.
Virology|June 1, 1976
Oligonucleotide mapping of picornavirus RNAs by two-dimensional electrophoresisD P Frisby, C Newton, N H Carey, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|January 1, 1984
Medical expenditures of terminal cancer patients during the last year of lifeS H Long, J O Gibbs, J P Crozier, et al.
The Veterinary Quarterly|July 4, 1998
Differentiating foot-and-mouth disease virus-infected from vaccinated animals with baculovirus-expressed specific proteinsJ M Mezencio, G D Babcock, R F Meyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 1994
Foot-and-mouth disease virus particles contain replicase protein 3DJ F Newman, P G Piatti, B M Gorman, et al.
Vaccine|September 29, 1999
Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motifF Brown, N Benkirane, D Limal, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Nature|June 11, 1987
Myristylation of picornavirus capsid protein VP4 and its structural significanceM Chow, J F Newman, D Filman, et al.
Virology|January 10, 1995
Characterization of an acid-resistant mutant of foot-and-mouth disease virusT Twomey, L L France, S Hassard, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 1994
Circular dichroism, molecular modeling, and serology indicate that the structural basis of antigenic variation in foot-and-mouth disease virus is alpha-helix formationL L France, P G Piatti, J F Newman, et al.
Journal of Virological Methods|April 1, 1997
Baculovirus expressed 2C of foot-and-mouth disease virus has the potential for differentiating convalescent from vaccinated animalsR F Meyer, G D Babcock, J F Newman, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 1997
A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long-lasting protective neutralizing antibodiesJ P Briand, N Benkirane, G Guichard, et al.
Virology|June 1, 1976
Oligonucleotide mapping of picornavirus RNAs by two-dimensional electrophoresisD P Frisby, C Newton, N H Carey, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|January 1, 1984
Medical expenditures of terminal cancer patients during the last year of lifeS H Long, J O Gibbs, J P Crozier, et al.
The Veterinary Quarterly|July 4, 1998
Differentiating foot-and-mouth disease virus-infected from vaccinated animals with baculovirus-expressed specific proteinsJ M Mezencio, G D Babcock, R F Meyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 1994
Foot-and-mouth disease virus particles contain replicase protein 3DJ F Newman, P G Piatti, B M Gorman, et al.
Vaccine|September 29, 1999
Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motifF Brown, N Benkirane, D Limal, et al.
Pageof 6